{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:23:06Z","timestamp":1778048586794,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:15:31Z","timestamp":1702998931000},"page":"S36-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S6","title":["Outpatient administration of high-dose methotrexate in adults without drug monitoring \u2013 a case-control study of risk factors for acute kidney injury"],"prefix":"10.1016","volume":"46","author":[{"given":"Camila","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-4086","authenticated-orcid":false,"given":"Eduardo M","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3181","authenticated-orcid":false,"given":"Wellington F","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.htct.2023.10.005_bib0001","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.htct.2023.10.005_bib0002","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.htct.2023.10.005_bib0003","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.htct.2023.10.005_bib0004","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2019004215","article-title":"Reduced\u2013dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study","volume":"135","author":"Pedrosa","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2023.10.005_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/16078454.2022.2052602","article-title":"Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation","volume":"27","author":"Silva","year":"2022","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.htct.2023.10.005_bib0006","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00277-020-04341-7","article-title":"Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma","volume":"100","author":"Bernard","year":"2021","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.htct.2023.10.005_bib0007","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MPH.0000000000001238","article-title":"Outpatient high-dose methotrexate for osteosarcoma: it's safe and feasible, if you want it","volume":"41","author":"Hendershot","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.htct.2023.10.005_bib0008","unstructured":"No Title [Internet]. [cited 2022 Nov 30]. Available from: https:\/\/icesp.org.br\/assistencia-ensino-pesquisa-e-gestao\/"},{"issue":"2","key":"10.1016\/j.htct.2023.10.005_bib0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.htct.2023.10.005_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"Summary of recommendation statements","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.htct.2023.10.005_bib0011","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pbc.21419","article-title":"The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue","volume":"50","author":"Zelcer","year":"2008","journal-title":"Pediatric Blood Cancer"},{"issue":"7","key":"10.1016\/j.htct.2023.10.005_bib0012","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/pbc.22772","article-title":"Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective","volume":"55","author":"Mahadeo","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.htct.2023.10.005_bib0013","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ncponc0953","article-title":"Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible","volume":"4","author":"Anderson","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"6","key":"10.1016\/j.htct.2023.10.005_bib0014","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3109\/10428194.2013.840780","article-title":"High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis","volume":"55","author":"May","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.htct.2023.10.005_bib0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hon.2759","article-title":"Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies","volume":"38","author":"Amitai","year":"2020","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.htct.2023.10.005_bib0016","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12185-020-03071-w","article-title":"Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma","volume":"113","author":"Nakano","year":"2021","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.htct.2023.10.005_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12185-021-03132-8","article-title":"Risk factors for high-dose methotrexate-induced nephrotoxicity","volume":"114","author":"Kawaguchi","year":"2021","journal-title":"Int J Hematol"},{"issue":"13","key":"10.1016\/j.htct.2023.10.005_bib0018","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2006-05-024414","article-title":"Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia","volume":"108","author":"Hijiya","year":"2006","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.htct.2023.10.005_bib0019","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.21.00471","article-title":"Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update","volume":"39","author":"Griggs","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.htct.2023.10.005_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/phar.2379","article-title":"Comparison of body size, morphomics, and kidney function as covariates of high-dose methotrexate clearance in obese adults with primary central nervous system lymphoma","volume":"40","author":"Pai","year":"2020","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"2","key":"10.1016\/j.htct.2023.10.005_bib0021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1078155213482602","article-title":"High-dose methotrexate in adult oncology patients: a case-control study assessing the risk association between drug interactions and methotrexate toxicity","volume":"20","author":"Chan","year":"2014","journal-title":"J Oncol Pharm Pract"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923025993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923025993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:06:20Z","timestamp":1737975980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923025993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":21,"alternative-id":["S2531137923025993"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.10.005","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient administration of high-dose methotrexate in adults without drug monitoring \u2013 a case-control study of risk factors for acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}